Oramed Pharmaceuticals Inc. (ORMP)
$4.33+3.10%Close
SELLBEAR · day 18
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $177M
- Beta
- 1.19
- Div yield
- 5.71%
- P/E (TTM)
- 1.04
- Short % float
- 4.54%
- Days to cover
- 7.3
- SI change
- +9.6%
- 1W
- -3.56%
- 1M
- -9.03%
- vs SPY 1W
- -4.72%
- vs SPY 1M
- -12.03%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ORMP?
- LOPJLB’s latest quantitative signal on Oramed Pharmaceuticals Inc. (ORMP) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is ORMP in?
- Oramed Pharmaceuticals Inc. (ORMP) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Oramed Pharmaceuticals Inc. (ORMP) do?
- Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes. The company's leading product, ORMD-0801, is an oral insulin capsule that has successfully complete…